Connecticut Study Seeks Scientific Answers To Myriad Questions About Medical Marijuana
The Yale School of Medicine and CT Pharma, a medical marijuana supplier, will team up for a human drug trial to test the effectiveness of marijuana-based medicine.
The study, approved by the federal Food and Drug Administration, will focus on the effectiveness of cannabinoid medicine at alleviating symptoms of stress and pain, said Dr. Rajita Sinha, the lead investigator for the clinical trial.
Sinha said she hopes the results will provide scientific answers to numerous questions about medical marijuana, ranging from how it works to whom it works for to what conditions it will alleviate.
“There are so many questions,” Sinha said during a news conference.
CT Pharma board chair Michael Fedele said he hopes the study will result in the first FDA-approved marijuana-based medicine to be manufactured in the United States.
“Right now, a company in England has the only FDA-approved, plant-based medical marijuana product in our market,” he said. “That really shouldn’t be the case with respect to American companies.” MORE »